Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies Meeting Abstract


Authors: Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Small, T. N.; Castro-Malaspina, H.; O'Reilly, R. J.
Abstract Title: Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies
Meeting Title: 49th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 110
Issue: 11 Pt. 1
Meeting Dates: 2007 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2007-11-01
Start Page: 878A
Language: English
ACCESSION: WOS:000251100804028
PROVIDER: wos
PUBMED: 18092369
Notes: --- - Meeting Abstract: 2991 - 49th Annual Meeting of the American-Society-of-Hematology - DEC 08-11, 2007 - Atlanta, GA - Part 1 - "Source: Wos"